Enanta Pharmaceuticals (ENTA) Tax Provisions (2014 - 2026)
Enanta Pharmaceuticals (ENTA) posted Tax Provisions of $7000.0 for Q1 2026, down 70.83% on a QoQ basis from $24000.0 in Q4 2025, and up 100.54% year-over-year from $3490.6 in Q1 2025.
Enanta Pharmaceuticals (ENTA) Tax Provisions (2014 - 2026) Analysis & Trends
Enanta Pharmaceuticals' Tax Provisions history runs 13 years deep, the most recent figure standing at $7000.0 for Q1 2026.
- Quarterly Tax Provisions rose 100.54% year-over-year to $7000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $92000.0 (up 103.71% YoY) and the FY2025 annual result came in at -$1.7 million, up 4.76% from the prior year.
- Tax Provisions was $7000.0 for Q1 2026 at Enanta Pharmaceuticals, down from $24000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $4.2 million in Q2 2023 and bottomed at -$3.9 million in Q3 2023.
- A 5-year average of -$219125.0 and a median of -$198500.0 in 2022 frame the typical range for Tax Provisions.
- Peak annual rise in Tax Provisions reached 1044.3% in 2023, while the deepest fall reached 28185.71% in 2023.
- Enanta Pharmaceuticals' Tax Provisions stood at -$34000.0 in 2022, then sank by 1729.41% to -$622000.0 in 2023, then soared by 33.12% to -$416000.0 in 2024, then soared by 105.77% to $24000.0 in 2025, then plunged by 70.83% to $7000.0 in 2026.
- Business Quant data shows ENTA's Tax Provisions at $7000.0 in Q1 2026, $24000.0 in Q4 2025, and $32000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Enanta Pharmaceuticals | 369.97 Mn | 206.20 Mn | - | 7,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,000.00 |
| Dec 31, 2025 | 24,000.00 |
| Sep 30, 2025 | 32,000.00 |
| Jun 30, 2025 | 29,000.00 |
| Mar 31, 2025 | -1.31 Mn |
| Dec 31, 2024 | -416,000.00 |
| Sep 30, 2024 | -363,000.00 |
| Jun 30, 2024 | -395,000.00 |
| Mar 31, 2024 | -363,000.00 |
| Dec 31, 2023 | -622,000.00 |
| Sep 30, 2023 | -3.93 Mn |
| Jun 30, 2023 | 4.22 Mn |
| Mar 31, 2023 | 44,000.00 |
| Dec 31, 2022 | -34,000.00 |
| Sep 30, 2022 | 14,000.00 |
| Jun 30, 2022 | -447,000.00 |
| Dec 31, 2021 | -36,000.00 |
| Sep 30, 2021 | 48.51 Mn |
| Jun 30, 2021 | -9.38 Mn |
| Mar 31, 2021 | 7.11 Mn |